Breathtec BioMedical Inc.


By |
Breathtec BioMedical Inc.


Breathtec Biomedical, Inc. (“Breathtec”) was formed to propel innovative research in the area of breath analysis as a medical screening tool. Our efforts are aimed at leading the development of commercially viable methods for the early screening of diseases such as lung & breast cancers, neurodegenerative diseases (eg: Alzheimer’s / Parkinson’s), tuberculosis, diabetes, liver disease and more.

Issuer Information

Exchange: CNQ
CEO: Guy LaTorre
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: In-Vitro Diagnos
$ 0.37 $ 0.07 (23.73%)
Last Price 0.37 Change $ 0.07 Change % 23.73 Tick N/A
Bid 0.36 Bid Size 18,500.00 Ask 0.37 Ask Size 2,000.00
Open 0.30 High 0.37 Low 0.29 Prev Close 0.30
Last Trade Volume 802,277 52 Wk Hi 0.52 52 Wk Low 0.065
Market Cap 20 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 54,752,024.00 EPS (TTM) -0.04 PE Ratio N/A Exchange CSE